270 related articles for article (PubMed ID: 12425363)
1. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy.
Dursun N; Dursun E; Alican D
Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
[TBL] [Abstract][Full Text] [Related]
4. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.
Wissel J; Heinen F; Schenkel A; Doll B; Ebersbach G; Müller J; Poewe W
Neuropediatrics; 1999 Jun; 30(3):120-4. PubMed ID: 10480205
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
9. Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children.
Kanellopoulos AD; Mavrogenis AF; Mitsiokapa EA; Panagopoulos D; Skouteli H; Vrettos SG; Tzanos G; Papagelopoulos PJ
Eur J Phys Rehabil Med; 2009 Dec; 45(4):501-6. PubMed ID: 20032908
[TBL] [Abstract][Full Text] [Related]
10. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy.
Fehlings D; Rang M; Glazier J; Steele C
J Pediatr; 2000 Sep; 137(3):331-7. PubMed ID: 10969256
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
13. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
14. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.
Kanovský P; Bares M; Severa S; Richardson A;
Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin as a treatment for infantile cerebral palsy].
Pascual-Pascual SI; Sánchez de Muniain P; Roche MC; Pascual-Castroviejo I
Rev Neurol; 1997 Sep; 25(145):1369-75. PubMed ID: 9377292
[TBL] [Abstract][Full Text] [Related]
17. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy.
Galli M; Cimolin V; Valente EM; Crivellini M; Ialongo T; Albertini G
Disabil Rehabil; 2007 Apr; 29(8):659-64. PubMed ID: 17453987
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin, physical and occupational therapy, and neuromuscular electrical stimulation to treat spastic upper limb of children with cerebral palsy: a pilot study.
Rodríguez-Reyes G; Alessi-Montero A; Díaz-Martínez L; Miranda-Duarte A; Pérez-Sanpablo AI
Artif Organs; 2010 Mar; 34(3):230-4. PubMed ID: 20447049
[TBL] [Abstract][Full Text] [Related]
20. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
